Havel & Partners has represented HP Tronic and NAY on merger clearance from the Czech Office for the Protection of Competition and the Slovak Antimonopoly Office for their merger.

A popular practice among consumers under the age of 30 is to purposely search for better-value alternatives to items from well-known brands. Started to gain followers on social media, this idea has become a phenomenon, with entrepreneurs setting up e-stores, boldly claiming to sell dupes (short for "duplicates"). Others sell their own products "inspired" by current trends. And while supply is generally justified by demand, it raises the question of whether duplicates are an innocent more affordable alternative or an unfair profiting on the back of another. Public opinion is divided, but we are going to examine what the law says.

On 26 April 2024, the Cabinet of Ministers of Ukraine (“Government”) approved the Procedure for Using Funds from the State Budget to Provide State Support for the Implementation of Investment Projects Involving Significant Investments (“Budget Procedure”).

Sayenko Kharenko has successfully represented Agrocenter, Zmiivska Ovocheva Fabryka, Kombinat Teplychny, Kremenchytska Ovocheva Fabryka, Ovochevyy Kombinat Stanyshivka, Perspektyva, Greenhouse Complex Dniprovsky, and Uman Greenhouse Complex in initiating anti-dumping investigation against imports into Ukraine of cucumbers and tomatoes originating from Turkiye.

This legislative monitoring report covers the introduction of new rules regulating public procurement in international relations, the adoption of the Free Trade Agreement between the Republic of Moldova and EFTA member states, the introduction of new rules regulating trademarks from 2027, the adoption of the regulation on audiovisual content. The document also provides for the approval of the regulation on the environmental management of mercury waste, the adoption of the law on hunting and the protection of game resources, the implementation of the national programme for the development of creative industries "Creative Moldova" for the years 2024-2027, as well as the optimisation of the use of industrial parks. 

In Serbia, most of the exclusivity arrangements between pharma companies need to be, prior to their implementation, individually exempt by the Serbian Competition Authority (“SCA”). Most recently, the SCA issued two decisions in the individual exemption process. In one it denied, while, in the other it only conditionally approved individual exemptions for exclusive distribution agreements between pharmaceutical companies. These developments show a noticeable shift in the SCA’s stand towards exclusivity arrangements with the SCA taking a stringent approach, limiting the parties' ability to contract exclusivity arrangements in the sector.